Reply to Skowronski and Chambers
Clin Infect Dis
.
2017 Jul 15;65(2):355.
doi: 10.1093/cid/cix376.
Authors
Allen C Cheng
1
2
,
Kristine K Macartney
3
4
,
Grant W Waterer
5
6
,
Tom Kotsimbos
7
,
Paul M Kelly
8
9
,
Christopher C Blyth
10
11
12
13
Affiliations
1
Infection Prevention and Healthcare Epidemiology Unit, Alfred Health.
2
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria.
3
National Centre for Immunisation Research and Surveillance.
4
Children's Hospital at Westmead, Syndey, New South Wales.
5
Royal Perth Hospital.
6
University of Western Australia (UWA), Perth, Western Australia.
7
Department of Allergy, Immunology, and Respiratory Medicine, Alfred Health, Melbourne.
8
ACT Health Directorate.
9
Australian National University Medical School, Canberra.
10
School of Paediatrics and Child Health, UWA, Perth.
11
Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, UWA.
12
Department of Infectious Diseases, Princess Margaret Hospital for Children, Subiaco.
13
Department of Microbiology, PathWest Laboratory Medicine, Perth, Australia.
PMID:
28431103
DOI:
10.1093/cid/cix376
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Hospitalization
Humans
Influenza Vaccines*
Influenza, Human*
Vaccination
Substances
Influenza Vaccines